COMMUNIQUÉS West-GlobeNewswire

OraSure Technologies to Present at the 36th Annual J.P. Morgan Healthcare Conference
05/01/2018
BETHLEHEM, Pa., Jan. 05, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR ), a leader in point of care diagnostic tests and specimen collection devices, today announced that Douglas A. Michels, [...]
Ohr Pharmaceutical Announces Efficacy Results from the MAKO Study in Wet-AMD
05/01/2018
NEW YORK, Jan. 05, 2018 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (NASDAQ: OHRP ), a clinical-stage pharmaceutical company developing novel therapies for ophthalmic diseases, today reported topline data from the MAKO [...]
BioCryst Advancing Potential Treatment for Rare and Severely Debilitating Fibrodysplasia Ossificans Progressiva
05/01/2018
RESEARCH TRIANGLE PARK, N.C., Jan. 05, 2018 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX ) announced today that it has advanced a program exploring activin receptor-like kinase-2 (ALK2) inhibitors [...]
TLC to Attend and Present at the 36th Annual JP Morgan Healthcare Forum
05/01/2018
TAIPEI, Taiwan, Jan. 05, 2018 (GLOBE NEWSWIRE) -- TLC (4152.TWO) today announced that it will be attending the 36 th annual JP Morgan Healthcare Conference in San Francisco on January 7-11, 2018. TLC President George [...]
Lundbeck enters research partnership on novel treatment of schizophrenia
05/01/2018
Valby, 2018-01-05 08:00 CET (GLOBE NEWSWIRE) -- H. Lundbeck A/S (Lundbeck) now adds another novel approach to its efforts to research and develop new and better treatments for schizophrenia. Forming a partnership with [...]
Motif Bio to participate in panel discussion at upcoming Cantor Antibiotics Summit
05/01/2018
NEW YORK, Jan. 05, 2018 (GLOBE NEWSWIRE) -- Motif Bio plc (AIM:MTFB) (NASDAQ: MTFB ), a clinical stage biopharmaceutical company specialising in developing novel antibiotics, announced today that the Company will [...]
Takeda announces its intention to acquire TiGenix
05/01/2018
PRESS RELEASE REGULATED INFORMATION Inside Information Communication in accordance with section 8, §1 of the Belgian Royal Decree of 27 April 2007 on public takeover bids Takeda announces its intention to acquire [...]
Takeda annonce son intention d'acquérir TiGenix
05/01/2018
COMMUNIQUÉ DE PRESSE INFORMATION RÉGLEMENTÉE INFORMATION PRIVILEGIEE Communication conformément à l'article 8, §1 de l'Arrêté Royal belge du 27 avril 2007 relatif aux offres publiques d'acquisition Takeda annonce son [...]
CRISPR Therapeutics Announces Pricing of Public Offering of Common Shares
05/01/2018
ZUG, Switzerland and CAMBRIDGE, Mass., Jan. 04, 2018 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP ), a biopharmaceutical company focused on developing transformative gene-based medicines for serious diseases, [...]
Micron Products, Inc. Announces New $9,500,000 Credit Facility
04/01/2018
FITCHBURG, Mass., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Micron Products, Inc. (“Micron”), a wholly owned subsidiary of Micron Solutions, Inc. (NYSE American:MICR), (“Micron Solutions”, collectively the “Company”) entered [...]
Veritas Pharma Provides Year End Update on Company’s Activities to Shareholders
04/01/2018
VANCOUVER, British Columbia, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt: 2VP ) , (“Veritas” or the “Company”) is pleased to provide an update to its prospective and current [...]
Obalon Schedules Fourth Quarter and Full Year 2017 Preliminary, Unaudited Revenue and Business Update Conference Call for January 5, 2018 at 8:30 a.m. Eastern Time
04/01/2018
SAN DIEGO, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN ), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric [...]
MacroGenics to Present at the 36th Annual J.P. Morgan Healthcare Conference
04/01/2018
ROCKVILLE, MD, Jan. 04, 2018 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]
K2M Group Holdings, Inc. to Present at the 36th Annual J.P. Morgan Healthcare Conference
04/01/2018
LEESBURG, Va., Jan. 04, 2018 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (NASDAQ: KTWO ) (the "Company" or "K2M"), a global leader of complex spine and minimally invasive solutions focused on achieving three- [...]
Amarin Provides Preliminary 2017 Results and Provides 2018 Outlook
04/01/2018
Unaudited Full-Year 2017 Net Product Revenue Estimated Between $177 and $180 Million, Exceeding Upper End of Previously Provided Guidance, with Fourth Quarter Estimate Between $51 and $54 Million Anticipate 2018 Net [...]
ConforMIS Announces Publication of Results published in the peer-reviewed Journal of Knee Surgery showing 100% of patients treated with iTotal CR achieve mechanical alignment in target range of +/- 3%
04/01/2018
BILLERICA, Mass., Jan. 04, 2018 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ: CFMS ), a medical technology company that offers joint replacement implants designed and manufactured to fit each patient’s unique anatomy, [...]
Atara Biotherapeutics to Present at the 36th Annual J.P. Morgan Healthcare Conference
04/01/2018
SOUTH SAN FRANCISCO, Calif., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA ), a leading off-the-shelf T-cell immunotherapy company developing novel treatments for patients with cancer, [...]
The Cooper Companies Declares Cash Dividend
04/01/2018
PLEASANTON, Calif., Jan. 04, 2018 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO ) today announced that, consistent with the plan approved by its board of directors to pay annual dividends, the Company [...]
MPX Comments on Attorney General Jeff Sessions’s Memo re: Marijuana Enforcement
04/01/2018
TORONTO, Jan. 04, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (the “ Company ” or “ MPX ”) (CSE:MPX) (OTC:MPXEF) would like comment on the memo issued today from the office of Jeffrey Sessions, Attorney General [...]

Pages